1. Home
  2. Analysis
  3. Telmisartan
  4. Skin-hypertrophy

Telmisartan and Skin hypertrophy - a phase IV clinical study of FDA data

Summary:

Skin hypertrophy is reported as a side effect among people who take Telmisartan (telmisartan), especially for people who are female, 50-59 old, have been taking the drug for 5 - 10 years also take Omeprazole, and have Fungal nail infection.

The phase IV clinical study analyzes which people have Skin hypertrophy when taking Telmisartan. It is created by eHealthMe based on reports of 8,644 people who have side effects when taking Telmisartan from the FDA, and is updated regularly.

What is Telmisartan?

Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.

What is Skin hypertrophy?

Skin hypertrophy (skin cells enlarges) is found to be associated with 588 drugs and 548 conditions by eHealthMe. Check the latest studies of Skin hypertrophy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

8,644 people reported to have side effects when taking Telmisartan.
Among them, 11 people (0.13%) have Skin hypertrophy.

Could Telmisartan cause Skin hypertrophy?

Among these 11 people:

How long have people been on Telmisartan when they have Skin hypertrophy? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 100 %
  • 10+ years: 0.0 %

What is the gender of people who have Skin hypertrophy when taking Telmisartan? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Skin hypertrophy when taking Telmisartan? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

What are other drugs people take besides Telmisartan? *

  1. Acetaminophen: 4 people, 36.36%
  2. Naftifine Hydrochloride: 4 people, 36.36%
  3. Omeprazole: 4 people, 36.36%
  4. Stivarga: 3 people, 27.27%
  5. Qinlock: 3 people, 27.27%
  6. Clonidine: 3 people, 27.27%
  7. Hydrochlorothiazide: 3 people, 27.27%
  8. Carvedilol: 3 people, 27.27%
  9. Amlodipine: 3 people, 27.27%
  10. Calcium: 1 person, 9.09%

What are other side effects people have besides Skin hypertrophy? *

  1. Skin Exfoliation (removal of the oldest dead skin cells): 7 people, 63.64%
  2. Rashes (redness): 7 people, 63.64%
  3. Blood Pressure Fluctuation: 4 people, 36.36%
  4. Dyspnea (difficult or laboured breathing): 4 people, 36.36%
  5. Itching: 4 people, 36.36%
  6. Skin Burning Sensation: 4 people, 36.36%
  7. Skin Discoloration: 4 people, 36.36%
  8. Weakness: 4 people, 36.36%
  9. Skin Wrinkling (wrinkle on skin): 4 people, 36.36%
  10. Hypersensitivity: 4 people, 36.36%

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 36.36%
  2. Fungal Nail Infection: 4 people, 36.36%
  3. Gastrointestinal Stromal Tumor: 3 people, 27.27%
  4. Essential Hypertension (primary hypertension): 3 people, 27.27%
  5. Systemic Sclerosis Pulmonary (an autoimmune or connective tissue disease. it is characterized by thickening of the skin with involvement of lungs): 1 person, 9.09%
  6. Retroperitoneal Fibrosis (a rare disorder that occurs when extra fibrous tissue forms in the area behind the stomach and intestines): 1 person, 9.09%
  7. Nausea (feeling of having an urge to vomit): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Telmisartan and have Skin hypertrophy?

- Check whether Skin hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Telmisartan:

Skin hypertrophy treatments and more:

How severe was Skin hypertrophy and when was it recovered:

Expand to all the drugs that have ingredients of telmisartan:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Telmisartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin hypertrophy:

Browse all the conditions that are associated with Skin hypertrophy:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on telmisartan (the active ingredients of Telmisartan) and Telmisartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.